VITX - new IPO with room to grow | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
VITX - new IPO with room to grow

An SI Board Since June 1998

Posts	SubjectMarks	Bans	Symbol
37	7	0	VITX

Emcee: Ariella	Type: Unmoderated

Introduction Market Data Compact

Excerpt from Hoovers: <<V.I. Technologies (VITEX) uses its proprietary viral inactivation technologies to eliminate dangerous viruses from its blood products, including plasma, red blood cells, and platelets. The company's transfusion plasma, created and distributed in conjunction with the American Red Cross under the name PLAS+SD, uses solvent/detergent viral inactivation technology to eliminate viruses such as hepatitis A, B, and C and HIV. VITEX has other strategic agreements with Bayer, United States Surgical Corporation, and Pall Corporation. The New York Blood Center (of which chairman David Tendler is a member of the board of trustees) owns about 29% of VITEX's stock. >>
ipocentral.com

Recent release: June 15, 1998--V.I. Technologies, Inc. (NASDAQ: VITX) announced today its strategic partner, Pall Corporation (NYSE: PLL), has purchased an additional $5 million of the Company's common shares in VITEX's Initial Public Offering, bringing its investment in the Company to $9 million.

VITEX and Pall Corporation are strategic collaborators in the development and marketing of systems employing viral inactivation technologies for red blood cell and platelet concentrates.

Pall Corporation previously invested $4 million in VITEX in a private placement. VITEX said that Pall has agreed to purchase an additional $17 million of VITEX common stock, at prevailing prices, if certain milestones are reached in the collaborative effort.

VITEX completed an Initial Public Offering on June 11, 1998, receiving net proceeds of $33,480,000.

VITEX is a leading developer of a broad portfolio of blood products and systems using its proprietary viral inactivation technologies. VITEX's technologies are intended to address the risk of viral contamination in blood products, including plasma, plasma derivatives, red blood cells and platelets.
_____________________________________
This stock came out at worst possible moment because of general market conditions. They were supposed to be priced in $13-$16 range; opened at $12 and sank to low $10s. Very interesting situation however. They have blood solvent process that washes viruses from blood and have great connections worldwide. American Red Cross has, I believe, an exclusive contract with them and other blood banks have started an anti-trust suit for fear their blood won't undergo the wash and, therefore, won't be in demand.

Anyone following this company?

--Ariella

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
37	VITX Removed from Naked Short List today! The link is: www.buyins.net Click o	Tom Ronk	-	4/25/2005
36	anyone still in this puppy, is this the same as VITXD ... what is that 'D&#	blind-geezer	-	4/5/2005
35	Food and Drug Administration Grants Fast Track Status for Panacos Pharmaceutical	kknightmcc	-	1/6/2005
34	Cerus Halts Trial for Blood Transfusion Safety Product Thursday September 4, 3:4	Matrix_Man	-	9/4/2003
33	Yes, I still like it. I know they are working on setting up phase three trials.	Matrix_Man	-	2/4/2001
32	I see vitx on your favorite list,is it still? What you think of run up today?	Preston Lurie	-	1/23/2001
31	Well, I have continued to accumulate on the lower rising trend line. I am now n	Matrix_Man	-	3/27/2000
30	Hi Matrix, I'm flat at present. Agree with you that VITX should be a 10 ba	Glenda King	-	3/9/2000
29	Glenda, you still here? Weren't you in RMBS? I have been accumulating VITX	Matrix_Man	-	3/9/2000
28	VITX CEO John Barr is scheduled for 11:30 AM Pacific Time today. This is a LIVE	shearson	-	12/7/1999
27	Whoops...spoke too soon...it backed off a little. Geez, I hate talking to mysel	Glenda King	-	12/4/1999
26	Hello, Is anybody home? Anyone besides me following this stock? Wanna hear som	Glenda King	-	12/3/1999
25	American Red Cross Accelerates Conversion to Plas+(R)SD WASHINGTON, Sept. 30 /	Ted Gregg	-	10/1/1999
24	V.I. Technologies to Merge with Pentose Pharmaceuticals biz.yahoo.com What do	Ted Gregg	-	7/29/1999
23	News Today : VITX Downgraded by SG Cowen from Strong Buy to Buy BUY is good e	Ted Gregg	-	6/22/1999
22	Here's news ;-) Vitex Receives $50 Million Minimum Order from the American	Ariella	-	12/21/1998
21	Sorta quiet here. Any news?	Dudley	-	11/16/1998
20	That doesn't seem "suspicious" to me, just unfortunate. On the ot	Ariella	-	10/24/1998
19	One thing that is suspicious about this stock is that the only recommendations	The Barracuda™	-	10/24/1998
18	Max, I sold the original shares at 17. Unfortunately bought again at the pullba	Ariella	-	10/21/1998
17	Ariella,this has got my interest may have bought some before you read this,are	LTK007	-	10/21/1998
16	Hi Yosi -- all good questions. I left the CFO number on the Yahoo thread. If th	Ariella	-	10/2/1998
15	Hi I have been looking at Vitex since it been IPO did any one look into pros	yosi s	-	10/1/1998
14	Dear Lurker, you've got to do better homework! "Lone customer" d	Ariella	-	9/25/1998
13	Pardon me, I'm a lurker with a question. From what little I understand abo	BomboochaBoy	-	9/25/1998

Go to reply# or date (mm/dd/yy):